Company / Depreciation & Amortization
Amgen Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$5.2B
FY2025
5-year range
$3.4B / $5.6B
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
#3 of 162
Health Care
What the data says
Among 162 Health Care companies, Amgen is in the bottom 2% for depreciation & amortization. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $1.9B in FY2018 to $5.6B in FY2024.
Based on SEC 10-K filings.
$5.2B in FY2025 with a 5-year CAGR of +7.5%. Ranks 3rd among 162 companies in Health Care.
Increased from $4.1B to $5.2B over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +14.8%
- 5-Year CAGR
- +7.5%
- 10-Year CAGR
- -
Sector benchmark
+2243.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.5%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 7.6% year-over-year.
- Ranks #3 out of 162 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2B | -7.6% |
| FY2024 | $5.6B | +37.4% |
| FY2023 | $4.1B | +19.1% |
| FY2022 | $3.4B | +0.6% |
| FY2021 | $3.4B | -5.6% |
| FY2020 | $3.6B | +63.2% |
| FY2019 | $2.2B | +13.4% |
| FY2018 | $1.9B | -0.5% |
| FY2017 | $2.0B | -7.1% |
| FY2016 | $2.1B | -0.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026